FILTER BY:

23
Use the form above to filter the list of products displayed or search for text using the Search by SmartText™ box, then click Apply to narrow the list of products shown. Note: the search box searches multiple text fields, including those not visible until you click the See Advanced Data View button.

Primary Biliary Cirrhosis Clinical Research Samples

Discovery Life Sciences provides the highest quality Primary Biliary Cirrhosis Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Primary Biliary Cirrhosis Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Product IDSampleOriginMatrixVial (ml)Vial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Test Data 1Sample Detail 1Test 2Test Data 2Sample Detail 2Test 3Test Data 3Sample Detail 3Product DetailsPriceAdditional Information 1Additional Data 1Additional Information 2Additional Data 2Additional Detail 2Additional Information 3Additional Data 3Additional Detail 3Additional Information 4Additional Data 4Additional Detail 4Additional Information 5Additional Data 5Additional Information 6Additional Data 6Additional Information 7Additional Data 7Additional Detail 7ICD10 codes
DLS16-13574-K2Primary Biliary CirrhosisItalyK2 EDTA Plasma11.005.00$150.0019FWhite<-70C05-Jul-16Clinical DiagnosisAutoimmune Hepatitis | Primary Biliary CirrhosisAutoimmune Hepatitis | Primary Biliary Cirrhosis$150.00Initial Date of Disease DiagnosisFeb-2016Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesNoneCurrent Prescription MedicationsDeursil
DLS16-13635-K2Primary Biliary CirrhosisCanadaK2 EDTA Plasma11.002.00$150.0069FWhite<-70C21-Sep-16Clinical DiagnosisPrimary Biliary CirrhosisPrimary Biliary Cirrhosis$150.00Initial Date of Disease DiagnosisFeb-2016Ever Developed JaundiceNoLiver BiopsyYes5-Feb-2016 (Mild chronic inflammatory activity)CirrhosisNoComorbiditiesHypertension; Pernicious anemiaCurrent Prescription MedicationsDiltiazem; Atacand; Aspirin; Vitamin B12; Ursodiol
DLS16-13636-K2Primary Biliary CirrhosisCanadaK2 EDTA Plasma11.005.00$150.0030MWhite<-70C21-Sep-16Clinical DiagnosisAutoimmune Hepatitis | Primary Biliary CirrhosisAutoimmune Hepatitis | Primary Biliary Cirrhosis$150.00Initial Date of Disease Diagnosis7-Dec-2015Ever Developed JaundiceYesSep-2015 (Hepatitis)Liver BiopsyYes13-Sep-2016 (Lymphocytic cholangitis; Interface hepatitis, Fibrous portal expansion)CirrhosisNoComorbiditiesNoneCurrent Prescription MedicationsAzathioprine; Prednisone; Ursodiol
DLS16-67212-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma11.001.00$150.0054FBlack<-70C14-Sep-16Clinical DiagnosisAutoimmune Hepatitis | Primary Biliary CirrhosisAutoimmune Hepatitis | Primary Biliary Cirrhosis$150.00Initial Date of Disease Diagnosis20-Sep-2012Ever Developed JaundiceNoLiver BiopsyNoCirrhosisYes4-Feb-2016 ComorbiditiesNoneCurrent Prescription MedicationsBenzoyl peroxide, Blood sugar stick/meter, Bumetanide, Carvedilol, Clindamycin, Clobetasol, Cyclosporine, Desonide cream, Ferrous sulfate, Hydroxyzine, Insulin aspart, NPH insulin, Spironolactone, Lisinopril, Metformin, Methimazole, Mycophenolate, Pantoprazole, Prednisolone, Psyllium
DLS16-67200-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma11.001.00$150.0056FWhite<-70C13-Dec-16Clinical DiagnosisPrimary Biliary CirrhosisPrimary Biliary CirrhosisCT LiverCirrhosis with splenomegaly suggests portal venous hypertension9-Oct-16$150.00Initial Date of Disease Diagnosis21-Mar-2007Ever Developed JaundiceNoLiver BiopsyYes21-Mar-2007 (Cirrhosis secondary to PBC)CirrhosisYesUltrasound guided liver biopsyComorbiditiesHyperlipidemia, Edema in legs, Hyperthyroidism, Anemia, PruritusCurrent Prescriptions MedicationsCalcium carbonate, Furosemide, Multivitamin, Omeprazole, Propanolol, Spironolactone, Ursodiol
DLS16-67214-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma11.001.00$150.0061FBlack<-70C18-Jan-17Clinical DiagnosisPrimary Biliary CirrhosisPrimary Biliary CirrhosisKidney ultrasoundNo evidence of obstructive uropathy1-Nov-13CT Abdomen and pelvisEnlarged myomatous uterus8-May-15$150.00Initial Date of Disease Diagnosis2001Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesStatus post liver transplant, Status post inguinal hernia repair, Uterine fibroid, Presbyopia, Episcleritis of left eye, Hypothyroidism Current Prescription MedicationsUrsodiol, Tacrolimus, Prednisone acetate, Levothyroxine
DLS16-13638-K2Primary Biliary CirrhosisCanadaK2 EDTA Plasma11.003.00$150.0050FWhite<-70C20-Feb-17Clinical DiagnosisPrimary Biliary CirrhosisPrimary Biliary CirrhosisUltrasoundCholelithiasis18-Jan-14N/AN/AN/A$150.00Initial Date of Disease Diagnosis25-Mar-2015Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesCREST SyndromeCurrent Prescription MedicationsUrsodiol; Ibuprofen
DLS16-82826-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma11.002.00$150.0044FWhite<-70C13-Mar-17Clinical DiagnosisPrimary Biliary CirrhosisPrimary Biliary CirrhosisUltrasoundCoarse hepatic echostructure16-May-13CTSuggestive of long standing hepatic impairment 1-Nov-13$150.00Initial Date of Disease Diagnosis11-Jun-2014Ever Developed JaundiceYesHyperbilirubinemia 2012Liver BiopsyNoCirrhosisYesSplenomegaly, Low platelet count, Elevated PT/INR/Bilirubin 1-Nov-2013 ComorbiditiesThrombocytopenia, Hyperbilirubinemia, Hyperlipidemia, Portal hypertension, GastritisCurrent Prescription MedicationsBaclofen, Simvastatin, Imitrex, Ergocalciferol, Propranolol, Urso Forte
DLS16-87712-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma1.004.00$150.0056MBlack<-70C28-Sep-17Clinical DiagnosisPrimary Biliary CirrhosisCT AbdoMenCirrhosis and portal hypertension. Upper abdoMinal ascites.29-Jul-17$150.00Initial Date of Disease DiagnosisMar-15Ever Developed JaundiceNoLiver BiopsyNoCirrhosis?YesCT AbdoMen 29-Jul-2017 ComorbiditiesAwaitng For organ transplant status, Esophageal varice, AdjustMent disorderCurrent Prescription medicationsCiproFloxacin HCL, Docusate sodiuM, Ferrous sulFate, FuroseMide, OMeprazole, Propanolol, SpironolactoneAll Known Test Results Performed in Previous Six monthsALT: 35 U/L, AST: 41 U/L Bilirubin (direct): 1.2 Mg/dL, Bilirubin (total): 2.6 Mg/dL 7-Jul-2017
DLS16-87726-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma1.005.00$150.0060FBlack<-70C20-Jun-17Clinical DiagnosisPrimary Biliary CirrhosisChest x-rayNorMal and No acute process 15-Jan-16 MRI AbdoMen Colonic diverticulosis. No evidence For cirrhosis.15-Oct-14$150.00Initial Date of Disease DiagnosisNov-2014Ever Developed JaundiceNoLiver BiopsyYesFindings are nonspeciFic and not unequivocally diagnostic For autoiMMune hepatis and priMary sclerosing cholangitis. 3-Nov-2014 Cirrhosis?NoComorbiditiesGERD, Fatty liver, Pre-diabetes, OsteopeniaCurrent Prescription medicationsAlbuterol, Atenolol, Benzonatate, Cetirizine, CholecalciFerol, Felodipine, Fluticasone, Lisinopril Mononitrate, Nitroglycerin, Ranitidine, UrodiolAll Known Test Results Performed in Previous Six monthsALT: 16 U/L, AST: 19 U/L Bilirubin (direct): <0.1 Mg/dL, Bilirubin (total): 0.3 Mg/dL 5-Jun-2017
DLS16-87726-SPrimary Biliary CirrhosisUSASerum1.001.00$150.0060FBlack<-70C20-Jun-17Clinical DiagnosisPrimary Biliary CirrhosisChest x-rayNorMal and No acute process 15-Jan-16 MRI AbdoMen Colonic diverticulosis. No evidence For cirrhosis.15-Oct-14$150.00Initial Date of Disease DiagnosisNov-2014Ever Developed JaundiceNoLiver BiopsyYesFindings are nonspeciFic and not unequivocally diagnostic For autoiMMune hepatis and priMary sclerosing cholangitis. 3-Nov-2014 Cirrhosis?NoComorbiditiesGERD, Fatty liver, Pre-diabetes, OsteopeniaCurrent Prescription medicationsAlbuterol, Atenolol, Benzonatate, Cetirizine, CholecalciFerol, Felodipine, Fluticasone, Lisinopril Mononitrate, Nitroglycerin, Ranitidine, UrodiolAbbott Architect Albumin: 4.6 g/dL ALP: 132 U/L ALT: 8 U/L AST: 16 U/L GGT: 33 U/L LD: 181 U/L Protein: 8.2 g/dL13-Mar-2018
DLS16-82810-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma1.001.00$150.0077FWhite<-70C12-Sep-17Clinical DiagnosisPrimary Biliary CirrhosisCTLiver cirrhosis29-Aug-14$150.00Initial Date of Disease Diagnosis2005Ever Developed JaundiceNoLiver BiopsyNoCirrhosisYes | 29-Aug-14CT scanComorbiditiesDuodenal ulcers, Anemia, DyslipidemaiCurrent Prescription MedicationsOmeprazole, Actigall, Plavix, Aspirin, WelcholAll Known Test Results Performed in Previous Six MonthsNone
DLS16-82848-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma1.005.00$150.0045FWhite<-70C03-Jul-17Clinical DiagnosisPrimary Biliary CirrhosisUltrasoundUnremarkable27-May-17$150.00Initial Date of Disease Diagnosis5-Jun-2017Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesPsoriatic arthritis, Status post-cholecystectomy and gastric bypass, ADHDCurrent Prescription MedicationsUrsodiol, Vyvanse, Adderall, Cymbalta, RestorilAll Known Test Results Performed in Previous Six MonthsALT: 100 U/L; AST: 106 U/L; GGT: 250 U/L; Bilirubin (direct): 0.12 mg/dL; Bilirubin (total): 0.2 mg/dL 26-May-2017;
DLS17-038155-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma1.004.00$150.0055FWhite<-70C31-Oct-17Clinical DiagnosisPrimary Biliary CirrhosisUltrasoundLiver has persistent increased echogenicity suggesting fatty deposits3-Sep-10MRI Cirrhotic changes of the liver parenchyma. No focal hepatic lesions. Mildly cirrhotic-appearing liver with splenomegaly2-Nov-16$150.00Initial Date of Disease Diagnosis18-Dec-2009Ever Developed JaundiceNoLiver BiopsyYes | Dec-09Non-alcoholic steatohepatitis with advanced fibrosis / pre-cirrhotic or near cirrhotic stateCirrhosisYes | 7-Dec-12MRIComorbiditiesHypertension, Diabetes, GERDCurrent Prescription MedicationsPantoprazole sodium, Ocaliva, Sucralfate, Lantus, NovologAll Known Test Results Performed in Previous Six MonthsALT: 23 U/L; AST: 37 U/L; Bilirubin (total): 0.4 mg/dL; Cholesterol: 203 mg/dL; Triglycerides: 215 mg/dL; HDL: 35 mg/dL; LDL: 132 mg/dL 31-Oct-2017
DLS16-13643-K2Primary Biliary CirrhosisCanadaK2 EDTA Plasma1.009.00$150.0054FWhite<-70C02-Feb-18Clinical DiagnosisPrimary Biliary CirrhosisUltrasoundMild Hepatomegaly, Splenomegaly, Cholelithiasis19-May-17$150.00Initial Date of Disease Diagnosis2004Ever Developed JaundiceNoLiver BiopsyYesPBC Stage 1 | 19-Jan-01 , PBC | 22-Sep-17CirrhosisNoComorbiditiesNoneCurrent Prescription MedicationsUrsodiolAll Known Test Results Performed in Previous Six monthsALT: 32 U/L | AST: 33 U/L | GGT: 133 U/L | Bilirubin (direct): 6 umol/L | Bilirubin (total): 13 umol/L 13-Jan-2018 | Chol: 6.47 mmol/L | Trig: 0.96 mmol/L HDL: 1.92 mmol/L | LDL: 4.11 mmol/L | 14-Sep-2017
DLS16-13643-SPrimary Biliary CirrhosisCanadaSerum1.003.00$150.0054FWhite<-70C02-Feb-18Clinical DiagnosisPrimary Biliary CirrhosisUltrasoundMild Hepatomegaly, Splenomegaly, Cholelithiasis19-May-17$150.00Initial Date of Disease Diagnosis2004Ever Developed JaundiceNoLiver BiopsyYesPBC Stage 1 | 19-Jan-01 , PBC | 22-Sep-17CirrhosisNoComorbiditiesNoneCurrent Prescription MedicationsUrsodiolAll Known Test Results Performed in Previous Six monthsALT: 32 U/L | AST: 33 U/L | GGT: 133 U/L | Bilirubin (direct): 6 umol/L | Bilirubin (total): 13 umol/L 13-Jan-2018 | Chol: 6.47 mmol/L | Trig: 0.96 mmol/L HDL: 1.92 mmol/L | LDL: 4.11 mmol/L | 14-Sep-2017
DLS16-13609-K2Primary Biliary CirrhosisCanadaK2 EDTA Plasma1.0010.00$150.0056FWhite<-70C16-Mar-18Clinical DiagnosisPrimary Biliary CirrhosisUltrasoundNormal Liver7-Jul-17$150.00Initial Date of Disease Diagnosis12-May-2017Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesNoneCurrent Prescription MedicationsUrsodialAll Known Test Results Performed in Previous Six monthsALT: 28 U/L | AST: 23 U/L | GGT: 72 U/L | Bilirubin (direct): 4 umol/L | Bilirubin (total): 12 umol/L 2-Feb-2018
DLS16-13609-SPrimary Biliary CirrhosisCanadaSerum1.007.00$150.0056FWhite<-70C16-Mar-18Clinical DiagnosisPrimary Biliary CirrhosisUltrasoundNormal Liver7-Jul-17$150.00Initial Date of Disease Diagnosis12-May-2017Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesNoneCurrent Prescription MedicationsUrsodialAll Known Test Results Performed in Previous Six monthsALT: 28 U/L | AST: 23 U/L | GGT: 72 U/L | Bilirubin (direct): 4 umol/L | Bilirubin (total): 12 umol/L 2-Feb-2018
DLS16-13610-K2Primary Biliary CirrhosisCanadaK2 EDTA Plasma1.009.00$150.0050FWhite<-70C16-Mar-18Clinical DiagnosisPrimary Biliary Cirrhosis$150.00Initial Date of Disease Diagnosis2008Ever Developed JaundiceNoLiver BiopsyYes | Grade 2 PBC; Stage 1 fibrosis2008CirrhosisNoComorbiditiesDepressionCurrent Prescription MedicationsUrsodial; Depo-Provera shotAll Known Test Results Performed in Previous Six monthsALT: 10 U/L | AST: 11 U/L | GGT: 11 U/L | Bilirubin (direct): <2 umol/L | Bilirubin (total): 3 umol/L 30-Jan-2018 | Chol: 4.69 mmol/L | Trig: 2.37 mmol/L | HDL: 1.44 mmol/L | LDL: 2.17 mmol/L | 13-Feb-2018
DLS16-13610-SPrimary Biliary CirrhosisCanadaSerum1.005.00$150.0050FWhite<-70C16-Mar-18Clinical DiagnosisPrimary Biliary Cirrhosis$150.00Initial Date of Disease Diagnosis2008Ever Developed JaundiceNoLiver BiopsyYes | Grade 2 PBC; Stage 1 fibrosis2008CirrhosisNoComorbiditiesDepressionCurrent Prescription MedicationsUrsodial; Depo-Provera shotAll Known Test Results Performed in Previous Six monthsALT: 10 U/L | AST: 11 U/L | GGT: 11 U/L | Bilirubin (direct): <2 umol/L | Bilirubin (total): 3 umol/L 30-Jan-2018 | Chol: 4.69 mmol/L | Trig: 2.37 mmol/L | HDL: 1.44 mmol/L | LDL: 2.17 mmol/L | 13-Feb-2018
KH18-16879Primary Biliary CirrhosisUSASerum2.001.00$75.0066MWhite<-70C13-Apr-18Abbott Architect20U/LALTAbbott Architect17 U/LAST$75.00BMI27.24Height | Weight177.8 | 86.1K74.3
KH18-16880Primary Biliary CirrhosisUSAK2 EDTA Plasma1.501.00$75.0066MWhite<-70C13-Apr-18Abbott Architect20U/LALTAbbott Architect17 U/LAST$75.00BMI27.24Height | Weight177.8 | 86.1K74.3
KH18-20393Primary Biliary CirrhosisUSASerum2.251.00$75.0078FWhite<-70C02-May-18Abbott Architect<6U/LALTAbbott Architect19 U/LAST$75.00BMI42.19Height | Weight157 cm | 104 kgK74.3

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.